Mesalamine Rectal is a Rectal Suppository in the Human Prescription Drug category. It is labeled and distributed by Amring Pharmaceuticals Inc.. The primary component is Mesalamine.
| Product ID | 69918-560_32848219-33c4-468e-b60e-e13caf9ebe02 |
| NDC | 69918-560 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mesalamine Rectal |
| Generic Name | Mesalamine |
| Dosage Form | Suppository |
| Route of Administration | RECTAL |
| Marketing Start Date | 2019-06-24 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208362 |
| Labeler Name | Amring Pharmaceuticals Inc. |
| Substance Name | MESALAMINE |
| Active Ingredient Strength | 1000 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-06-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA208362 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-06-24 |
| Ingredient | Strength |
|---|---|
| MESALAMINE | 1000 mg/1 |
| SPL SET ID: | 87de237c-febb-42ca-b2a4-b444396f8640 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69918-560 | Mesalamine Rectal | Mesalamine Rectal |
| 0023-5901 | Asacol HD | mesalamine |
| 0430-0783 | ASACOL HD | mesalamine |
| 0023-5853 | Delzicol | mesalamine |
| 0179-0142 | Lialda | mesalamine |
| 0093-5907 | Mesalamine | Mesalamine |
| 0093-9224 | mesalamine | mesalamine |
| 0378-1375 | Mesalamine | mesalamine |
| 0378-9230 | Mesalamine | mesalamine |
| 0472-1915 | Mesalamine | Mesalamine |
| 0037-0066 | Rowasa | mesalamine |
| 0037-0022 | sfRowasa | mesalamine |